A phase II study of single agent depsipeptide (DEP) in patients (pts) with radioactive iodine (RAI)-refractory, metastatic, thyroid carcinoma: Preliminary toxicity and efficacy experience
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Y. B. Su, R. M. Tuttle, M. Fury, R. Ghossein, B. Singh, K. Herman, E. S. Venkatraman, H. Stambuk, R. Robbins, D. G. Pfister
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2247458899
